(7 years, 2 months ago)
Commons ChamberIt is abundantly clear, especially from the Westminster Hall debate secured by the hon. Member for Ynys Môn (Albert Owen), that Euratom is intrinsically entwined with our membership of the European Union. Legal advice says that, as does the Commission itself. That has been abundantly expressed during this debate, and no doubt it will be expressed again on many other occasions.
The tone of the Westminster Hall debate, and the contribution it made, was fantastic. Unfortunately, some aspects of the issue, as we have heard today, are actually a little more disturbing. The way the debate is going on medical isotopes—radioactive isotopes for cancer and other medical treatments—has been extraordinary, given that it is absolutely clear that this does not form part of the Bill. The impact of leaving Euratom will not be to stop people receiving such cancer treatments.
I thank the hon. Gentleman for referring to the debate I led on 12 July. There was consensus in that debate in the Grand Committee Room that we should have associate membership of Euratom. That was the general theme of what was said by Members from both sides of the House, and we need to move towards it. In particular, I do not think that the Bill provides the lifeboat necessary for us to leave Euratom. Many of us are arguing for a transition period so that we will remain in Euratom until we get either associate membership or third-party agreements.
I appreciate the broad consensus in the Grand Committee Room, but not everyone had an opportunity to speak in that debate. No doubt there will be a transition period of some sort, but whether we have an associate membership or just a very close association at the end of it—like the association we will have with the European Union—we will look at what the EU does and how it goes about things, and we of course want similar standards. We are not looking to leave the European Union and then to reduce and cut all kinds of standards.